AC Immune

Early data from AC Immune Alzheimer's vaccine suggests a response, setting up next phase of study
Early data from AC Immune Alzheimer's vaccine suggests a response, setting up next phase of study
Fierce Biotech
AC Immune
Alzheimer's disease
clinical trials
vaccines
ACI-24.060
Flag link:
J&J unit, happy with AC Immune Alzheimer's work, moves 1 of 2 shots to next step
J&J unit, happy with AC Immune Alzheimer's work, moves 1 of 2 shots to next step
Fierce Biotech
JNJ
AC Immune
Alzheimer's disease
Janssen
vaccines
ACI-35.030
Flag link:
AC Immune's Janssen-partnered Alzheimer's vaccine spurs tau-attacking antibodies in early-stage trial
AC Immune's Janssen-partnered Alzheimer's vaccine spurs tau-attacking antibodies in early-stage trial
Fierce Biotech
AC Immune
Janssen
JNJ
vaccines
Alzheimer's disease
clinical trials
Flag link:
Roche, AC Immune attempt to flesh out anti-tau Alzheimer's data, but the forecast remains cloudy
Roche, AC Immune attempt to flesh out anti-tau Alzheimer's data, but the forecast remains cloudy
Endpoints
AC Immune
Roche
anti-tau antibodies
Alzheimer's disease
Flag link:
AC Immune claims a tau win in Alzheimer’s
AC Immune claims a tau win in Alzheimer’s
EP Vantage
AC Immune
Alzheimer's disease
semorinemab
clinical trial
Flag link:
AC Immune acquires Parkinson’s vaccine candidate
AC Immune acquires Parkinson’s vaccine candidate
Biopharma Reporter
AC Immune
Affris
vaccines
Parkinson's Disease
Flag link:
Second-quarter catalysts for the smaller players
Second-quarter catalysts for the smaller players
EP Vantage
AC Immune
Anavex
Santhera
IMMUTEP
Syndax
Novan
Fulcrum Therapeutics
BeyondSpring
Corbus
Orphazyme
Aldeyra
Adaptimmune
Inflarx
Sutro
Gemini Therapeutics
Flag link:
AC Immune has 'remarkable' Alzheimer's vaccine data. Just don't ask to see them
AC Immune has 'remarkable' Alzheimer's vaccine data. Just don't ask to see them
Endpoints
AC Immune
Alzheimer's disease
vaccines
clinical trials
Flag link:
Roche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved
Roche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved
Fierce Biotech
Roche
AC Immune
Alzheimer's disease
semorinemab
Flag link:
Alzheimer’s catalysts round off a year dominated by Biogen
Alzheimer’s catalysts round off a year dominated by Biogen
EP Vantage
Alzheimer's disease
Roche
Eli Lilly
AC Immune
Biohaven
Cortexyme
Biogen
Flag link:
AC Immune's Tau Vaccine for Alzheimer's Advanced into Phase Ib/II Clinical Trials
AC Immune's Tau Vaccine for Alzheimer's Advanced into Phase Ib/II Clinical Trials
BioSpace
AC Immune
clinical trials
ACI-35.030
Alzheimer's disease
Flag link:
5 Biotech Stocks Set to Beat Q3 Earnings Estimates
5 Biotech Stocks Set to Beat Q3 Earnings Estimates
Yahoo/Zacks.com
earnings
biotech
Eyenovia
SAGE Therapeutics
AC Immune
Ascendis
NGM Biopharmaceuticals
Flag link:
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test
Xconomy
Roche
Alzheimer's disease
clinical trials
AC Immune
crenezumab
Biogen
aducanumab
Flag link:
Lilly pays AC Immune $81M upfront for preclinical Alzheimer’s drug
Lilly pays AC Immune $81M upfront for preclinical Alzheimer’s drug
Fierce Biotech
Eli Lilly
AC Immune
Alzheimer's disease
tau
Flag link:
Roche to start new trial of AC Immune drug against Alzheimer's
Roche to start new trial of AC Immune drug against Alzheimer's
Yahoo/Reuters
Roche
AC Immune
Alzheimer's disease
clinical trials
crenezumab
Flag link:
Lilly's Setback Raises Stakes for Other Alzheimer Drug Companies
Lilly's Setback Raises Stakes for Other Alzheimer Drug Companies
TheStreet.com
Eli Lilly
Alzheimer's disease
solanezumab
AC Immune
Axovant
Biogen
Merck
Roche
Flag link:
Embracing biotech, Nestlé recruits AC Immune for an Alzheimer's project
Embracing biotech, Nestlé recruits AC Immune for an Alzheimer's project
Fierce Biotech
Alzheimer's disease
Nestle
AC Immune
R&D
Flag link:
J&J strikes Alzheimer's deal with AC Immune worth up to $509 mln
J&J strikes Alzheimer's deal with AC Immune worth up to $509 mln
Yahoo/Reuters
JNJ
Alzheimer's disease
AC Immune
anti-tau vaccines
Flag link:
Swiss biotech firm starts new Alzheimer vaccine trial
Swiss biotech firm starts new Alzheimer vaccine trial
Reuters
vaccines
Switzerland
Alzheimer's disease
AC Immune
ACI-35
Flag link:
Top 20 biotech licensing deals in H1 2012
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
Flag link:

Pages